$AWHL · Aspira Women's Health Inc. SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for Aspira Women's Health Inc. ($AWHL) from November 17, 2026 through November 17, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$AWHL 8-K — Aspira Women's Health Inc.
A non-reliance determination and material weakness disclosure signal control failures that can precede further restatements or regulatory scrutiny.
$AWHL 10-Q — Aspira Women's Health Inc.
A diagnostics company with $12,000 in cash and a going-concern warning faces an acute liquidity crisis despite a headline quarterly profit.